M&A Corner
Sun Pharma to Acquire Taro’s 100% Stake in All-Cash06 Jun 2023
Sun Pharma, India’s largest pharmaceutical company, plans to acquire the outstanding stake in its US subsidiary, Taro Pharma, in a... Continue Reading
|
Healthcare Costs Exceed $31K for Family of Four06 Jun 2023
According to the 2023 Milliman Medical Index, healthcare costs for a typical American family of four have reached $31,065 this... Continue Reading
|
Accenture to Acquire Brazilian Sustainability Consultancy Green Domus06 Jun 2023
Accenture plans to acquire Brazilian sustainability consultancy Green Domus to enhance its Sustainability Services team. Green Domus offers mitigation plans... Continue Reading
|
Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals29 May 2023
Adamis Pharmaceuticals Corporation has announced the completion of its merger with DMK Pharmaceuticals Corporation. The combined company will focus on... Continue Reading
|
eMolecules Acquires Specs Compound Handling B.V.29 May 2023
eMolecules, a chemical compound search-and-fulfillment platform for early discovery chemistry research, has announced the acquisition of Specs Compound Handling B.V.... Continue Reading
|
Medtronic to Acquire Wearable Insulin Patch Maker EOFlow29 May 2023
Medtronic, a global leader in healthcare technology, has announced its plans to acquire EOFlow, the manufacturer of the EOPatch device,... Continue Reading
|
UNC Health to Pilot Epic, Microsoft’s Generative AI Tool29 May 2023
UNC Health is set to become one of the early adopters of Generative AI (Artificial Intelligence) tools through a program... Continue Reading
|
Florence Acquires Telehealth Platform Zipnosis from Bright Health29 May 2023
Healthcare enablement software company Florence has acquired Zipnosis, an asynchronous-first virtual care solution, in an undisclosed all-cash deal. The acquisition... Continue Reading
|
Pyxis Oncology to Acquire Apexigen29 May 2023
Pyxis Oncology has announced its acquisition of Apexigen in an all-stock transaction valued at approximately $16 million. The acquisition will... Continue Reading
|
Ironwood to Pay $1B to Acquire VectivBio, Late-Stage Digestive Therapy29 May 2023
Ironwood Pharmaceuticals has announced its acquisition of VectivBio in a cash deal worth approximately $1 billion. The acquisition will expand... Continue Reading
|